Melatonin Neurim 欧州連合 - クロアチア語 - EMA (European Medicines Agency)

melatonin neurim

rad neurim pharmaceuticals eec sarl - melatonin - poremećaji uvođenja i održavanja spavanja - psycholeptics - melatonin neurim is indicated as monotherapy for the short-term treatment of primary insomnia characterised by poor quality of sleep in patients who are aged 55 or over.

Ztalmy 欧州連合 - クロアチア語 - EMA (European Medicines Agency)

ztalmy

marinus pharmaceuticals emerald limited - ganaxolone - epileptic syndromes; spasms, infantile - drugi antiepileptici sredstva - ztalmy is indicated for the adjunctive treatment of epileptic seizures associated with cyclin-dependent kinase-like 5 (cdkl5) deficiency disorder (cdd) in patients 2 to 17 years of age. ztalmy may be continued in patients 18 years of age and older.

Twinrix Paediatric 欧州連合 - クロアチア語 - EMA (European Medicines Agency)

twinrix paediatric

glaxosmithkline biologicals s.a. - hepatitis a virus (inactivated), hepatitis b surface antigen - immunization; hepatitis b; hepatitis a - cjepiva - twinrix pedijatrijskih je indiciran za uporabu u sobe imunološki dojenčadi, djece i adolescenata od jedne godine do i uključujući 15 godina koji su u opasnosti od oba hepatitisa a i hepatitisa b infekcije.

Jemperli 欧州連合 - クロアチア語 - EMA (European Medicines Agency)

jemperli

glaxosmithkline (ireland) limited - dostarlimab - endometrial neoplasms - antineoplastic agents and antibody drug conjugates - jemparli is indicated as monotherapy for the treatment of adult patients with mismatch repair deficient (dmmr)/microsatellite instability-high (msi h) recurrent or advanced endometrial cancer (ec) that has progressed on or following prior treatment with a platinum-containing regimen.

Dimethyl fumarate Mylan 欧州連合 - クロアチア語 - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - dimetil fumarat - multipla skleroza, Рецидивно-Ремиттирующее - imunosupresivi - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Edistride 欧州連合 - クロアチア語 - EMA (European Medicines Agency)

edistride

astrazeneca ab - dapagliflozin propandiol monohidrat - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - lijekovi koji se koriste u dijabetesu - type 2 diabetes mellitusedistride is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. osim drugih lijekova za liječenje šećerne bolesti tipa 2 . for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 i 5. heart failureedistride is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseedistride is indicated in adults for the treatment of chronic kidney disease.

Dapagliflozin Viatris 欧州連合 - クロアチア語 - EMA (European Medicines Agency)

dapagliflozin viatris

viatris limited - dapagliflozin - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - lijekovi koji se koriste u dijabetesu - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance. - in addition to other medicinal products for the treatment of type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 i 5. heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction. chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.

FLUTIFORM 50 µg/1 doza+ 5 µg/1 doza suspenzija za inhaliranje pod pritiskom ボスニア・ヘルツェゴビナ - クロアチア語 - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

flutiform 50 µg/1 doza+ 5 µg/1 doza suspenzija za inhaliranje pod pritiskom

medis international d.o.o. sarajevo - flutikazon, formoterol - suspenzija za inhaliranje pod pritiskom - 50 µg/1 doza+ 5 µg/1 doza - 1 doza sadrži: 50 µg flutikazon propionata 5 µg formoterol fumarat dihidrata

FLUTIFORM 125 µg/1 doza+ 5 µg/1 doza suspenzija za inhaliranje pod pritiskom ボスニア・ヘルツェゴビナ - クロアチア語 - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

flutiform 125 µg/1 doza+ 5 µg/1 doza suspenzija za inhaliranje pod pritiskom

medis international d.o.o. sarajevo - flutikazon, formoterol - suspenzija za inhaliranje pod pritiskom - 125 µg/1 doza+ 5 µg/1 doza - 1 doza sadrži: 125 µg flutikazon propionata 5 µg formoterol fumarat dihidrata

FLUTIFORM 250 µg/1 doza+ 10 µg/1 doza suspenzija za inhaliranje pod pritiskom ボスニア・ヘルツェゴビナ - クロアチア語 - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

flutiform 250 µg/1 doza+ 10 µg/1 doza suspenzija za inhaliranje pod pritiskom

medis international d.o.o. sarajevo - flutikazon, formoterol - suspenzija za inhaliranje pod pritiskom - 250 µg/1 doza+ 10 µg/1 doza - 1 doza sadrži: 250 µg flutikazon propionata 10 µg formoterol fumarat dihidrata